Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Urology|March 11, 2006
Translating overactive bladder questionnaires in 14 languagesCatherine Acquadro, Zoe Kopp, Karin S Coyne, et al.
BJU International|July 2, 2010
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancerTarek A Bismar, Maisa Yoshimoto, Robin T Vollmer, et al.
The Canadian Journal of Urology|August 4, 2004
A survey of urological manpower, technology, and resources in CanadaPeter Pommerville, S Larry Goldenberg, James W L Wilson, et al.
Gastroenterology|February 24, 2004
Symptom severity and QOL scales for urinary incontinenceMichelle J Naughton, Jenny Donovan, Xavier Badia, et al.
Neurourology and Urodynamics|March 3, 2015
Differences in pelvic floor morphology between continent, stress urinary incontinent, and mixed urinary incontinent elderly women: An MRI studyStéphanie Pontbriand-Drolet, An Tang, Stephanie J Madill, et al.
European Urology|October 1, 2008
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus reportApostolos Apostolidis, Prokar Dasgupta, Pierre Denys, et al.
Cancer Biology & Therapy|December 24, 2010
Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zoneShuhong Liu, Maisa Yoshimoto, Kiril Trpkov, et al.
BJU International|August 2, 2006
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension studyFrançois Haab, Jacques Corcos, Paul Siami, et al.
Neurourology and Urodynamics|November 18, 2017
An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)Jerzy B Gajewski, Brigitte Schurch, Rizwan Hamid, et al.
BJU International|January 25, 2006
Distribution of neuropeptide Y-containing nerves in the neurogenic and non-neurogenic detrusorAxel Haferkamp, Thomas Freund, Nina Wagener, et al.
Pageof 19